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    ABSTRACT 
 
The risk of urinary tract infection (UTI) in pregnant women is increased and predisposes them 
to acute pyelonephritis together with poor pregnancy outcomes. Increased frequency of 
micturition, nocturia and lower abdominal discomfort are common non-specific complaints 
during pregnancy, which render clinical diagnosis of UTI inaccurate. To prevent undesirable 
effects on the growing fetus, antimicrobial agents used in management of UTI during 
pregnancy should be carefully selected. In this thesis, we investigated virulence determinants 
and susceptibility of E. coli to antimicrobial agents and evaluated the possibility for medical 
staff - with limited training in microbiology - to evaluate easy-to-use tests for the diagnoses of 
UTI. The easy-to-use tests included nitrite, leucocyte esterase, urine microscopy and dipslide. 
Further, we evaluated the impact of vitamin D on innate immunity during pregnancy as well as 
the in vitro effects of Labisia pumila var. alata - a medicinal herb - on E. coli infected 
uroepithelial cells. 
 
E. coli resistance to antimicrobial agents differs by region and is influenced to some extent by 
virulence characteristics of the bacteria. We hypothesized that antibiotic resistance and 
virulence characteristics of E. coli differ depending on the use of antibiotics. We report 
significantly higher prevalence of antibiotic resistance among isolates from Uganda and 
Vietnam compared to those from Sweden. Presence of the flu gene was associated with 
increased risk of antibiotic resistance. 
The high prevalence of antibiotic resistance seen in Uganda is partly due to limited access to 
microbiology services. In comparison to urine culture, 96% of pregnant women diagnosed 
based on symptoms mimicking those of urinary tract infection freely received unnecessary 
antibiotics. We therefore evaluated nitrite, leucocyte esterase, leucocyturia and dipslide in 
outpatient settings as a way of reducing antibiotic misuse. We demonstrated high specificity, 
but low sensitivity of the combined nitrite and leucocyte esterase tests. There was poor 
correlation between leucocyte esterase and leucocyturia as analyzed by microscopy. Nurses 
and gynaecologist with limited knowledge of microbiology correctly diagnosed E. coli with a 
simplified culture method – the dipslide test.  
 
During pregnancy, vitamin D is required for development of the fetal skeleton, but it is also 
important for innate immunity. The major source of vitamin D is sunlight. Although Uganda 
has high sun exposure the whole year, persons with dark pigmented skin may not be able to 
optimally synthesize vitamin D. We found vitamin D as well as the antimicrobial peptide LL-
37 - that is induced by vitamin D, increased with advancing gestational age. There were 
significantly higher levels in the third compared to the first trimester. Furthermore, serum had 
increased bactericidal activity with increasing vitamin D levels. Conversely, IL-8 decreased 
with advancing gestational age. In vitro, vitamin D decreased expression of IL-8 in a dose-
dependent manner potentially modifying the inflammatory response to infection. 
 
The breakaway resistance to antibiotics recommended in management of UTI calls for 
alternative intervention that could be used alone or in combination with antibiotic therapy. The 
mechanisms of action of many medicinal herbs with potential disease-modifying effects have 
not been elucidated. We evaluated the medicinal herb Labisia pumila var. alata (LPva) – a herb 
whose effects on female genital conditions are widely reported but whose mode of action in 
UTI is not properly understood. LPva was not bactericidal but prevented bacterial invasion by 
down regulating β1 integrin and it also induced apoptosis in a dose-dependent manner.  
 
In conclusion, management of UTI in pregnancy will be improved by using effective 
antibiotics coupled with improved diagnostics. More vigorous interrogation of medicinal herbs 
hold promise for alternative therapies. We demonstrate for the first time the variation of LL-37 
during pregnancy; given impaired vitamin D synthesis among dark-skinned persons, 
fortification of food especially for pregnant women needs to be considered. 
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1 INTRODUCTION  
Urinary tract infections are the most common bacterial infection in women (Foxman 2010). This 
is mainly attributed to the short urethra and colonization of the peri-urethral area by pathogens 
from the gastro-intestinal tract. From the peri-urethral area, pathogens ascend to colonize the 
urinary bladder or kidneys (Bacheller and Bernstein 1997). In pregnancy, acute pyelonephritis is 
associated with spontaneous preterm birth and septicemia (Wing, Fassett et al. 2013). With 
advancing gestational age, increased frequency of micturition and lower abdominal discomfort 
are common complaints. It is therefore likely that clinical diagnosis of UTI maybe less accurate 
in pregnant compared to non-pregnant women. The higher prevalence of UTI in women 
compared to men led to description of honeymoon cystitis among newly married women 
(Buckley, McGuckin et al. 1978). A surgical procedure was designed for the management of 
recurrent symptoms of post-coital cystitis (Smith, Roberts et al. 1982). 
In this thesis, the prevalence of antimicrobial resistance and diagnosis of UTI in settings with 
limited access to microbiological services were investigated. In addition, the roles of vitamin D, 
antimicrobial peptides and LPva – a phytoestrogenic herb – in the pathogenesis of UTI were 
explored. 
 
1.1 URINARY TRACT INFECTIONS IN WOMEN 
Women between 16 and 35 years of age are 40 times more likely than men to develop UTI and 
about 25% of them suffer a recurrent infection within 6 months (Foxman 2002). Among women 
of reproductive age, asymptomatic bacteriuria (ABU) is commonly transient and requires no 
antibiotic therapy (Hooton, Scholes et al. 2000). However, during pregnancy, 20% to 30% of 
women with ABU develop acute pyelonephritis (Little 1966). Screening and treating ABU 
during pregnancy to reduce the risk of acute pyelonephritis is recommended and widely practiced 
in developed countries (Smaill 2001). However, with more rigorous study designs to establish 
the association between ABU and acute pyelonephritis in pregnancy, the beneficial effects of 
screening for ABU in pregnancy have been questioned (Kazemier, Koningstein et al. 2015).  The 
main causative organism of UTI in women is E. coli accounting for up to 85% of infections 
(Salvatore, Cattoni et al. 2011). The rest of the infections are attributed to other 
Enterobacteriaceae and Gram positive bacteria (Ronald 2002).  
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2 PATHOGENESIS OF UTI 
In the host-pathogen interaction during UTI, the pathogen adheres, invades and survives in the 
uroepithelium (Figure 1), acquires essential nutrients and may deploy toxins to disrupt host cell 
function (Mulvey, Lopez-Boado et al. 1998, Justice, Hung et al. 2004). The host response 
includes production of antimicrobial peptides (Chromek, Slamova et al. 2006), chemokines that 
recruit neutrophils (Hedges and Svanborg 1994) and apoptosis of umbrella cells.  
 
 
 
Figure 1: Bacteria adhere to bladder epithelial cells leading to production of antimicrobial peptides and 
chemokines/cytokines subsequently recruiting neutrophils. The combined effects of antimicrobial peptides 
and neutrophils are killing of pathogens. However, some pathogens invade bladder epithelial cells and         
form intracellular bacterial communities thus evading the host immune response. Both extra- and intra-
cellular bacteria induce apoptosis of bladder epithelial cells. 
 
2.1 Uropathogenic E.coli 
Uropathogenic E. coli (UPEC) is a subset of extra-intestinal pathogenic E. coli associated with 
urinary tract infections (Dale and Woodford 2015) and may colonize the host gastro-intestinal 
tract from which it spreads to cause UTI (Nielsen, Dynesen et al. 2014). UPEC possess flagella 
that facilitate propulsion against urine flow, adhere and invade epithelial cells using fimbrial and 
afimbrial adhesive organelles, are able to multiply in terminally differentiated and 
undifferentiated bladder epithelial cells leading to formation of intracellular bacterial 
communities and quiescent intracellular reservoirs respectively.  Secrete toxins that disrupt host 
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cell function, can be enclosed in polymeric material that protects them against host defenses 
(Figure 2). Collectively, these adaptations of UPEC are referred to as virulence factors.  
  
 
Figure 2: E. coli express virulence and fitness factors that facilitate its ability to colonize; evade host 
immune responses and persist in the urinary tract. Ag43 – Antigen 43, CNF1 – cytotoxic necrotizing 
factor 1, LPS – lipopolysaccharides. (Adopted from Luthje and Brauner 2014, Adv Microb Physiol.) 
 
There is no specific combination of virulence factors that characterize UPEC but they broadly 
express genes that mediate adhesion, invasion, immune evasion, promote acquisition of iron and 
secretion of toxins (Kaper, Nataro et al. 2004). These factors are mostly found on mobile genetic 
elements referred to as pathogenicity islands (Gal-Mor and Finlay 2006). E. coli are generally 
classified into four phylogenetic groups (Clermont, Bonacorsi et al. 2000). Majority of UPEC 
belong to phylogenetic group B2 and to some extent group D while most commensal isolates 
belong to phylogenetic group B1 and A (Ewers, Li et al. 2007). Correspondingly, isolates 
belonging to phylogenetic group B2 have higher virulence factor scores compared to those of 
phylogenetic groups B1 and A (Moreno, Andreu et al. 2008). However, apart from phylogenetic 
group and virulence factor score, there are pathogen and host factors that influence the ability of 
a given strain to cause UTI (Moreno, Andreu et al. 2008).  
 
     2.1.1 Adhesion and invasion of uroepithelial cells 
UPEC express fimbrial and afimbrial adhesins (Luthje and Brauner 2014). Type 1 fimbriae are 
one of the main adhesins that mediate irreversible binding to uroepithelial cells (Bahrani-
   4 
Mougeot, Buckles et al. 2002). Expression of type 1 fimbria is not exclusive to ExPEC, however, 
its deletion among pathogenic E. coli severely attenuates adhesion, invasion and the host 
inflammatory response (Connell, Agace et al. 1996).  
 
Type 1 fimbriae are synthesized through the chaperone-usher pathway (Lillington, Geibel et al. 
2014). The tip adhesin on type 1 fimbria irreversibly binds uroplakins 1a on bladder epithelial 
cells that mediates adhesion (Zhou, Mo et al. 2001). Conversely, interaction between fimH and 
host β-1 integrin leads to internalization of UPEC by a zippering mechanism (Eto, Jones et al. 
2007). 
 
For long, E. coli were considered extracellular pathogens, however, their discovery 
intracellularly has since changed this norm (Martinez, Mulvey et al. 2000). However, E. coli 
escape into the cell cytoplasm and rapidly multiply to form multicellular communities referred to 
as intracellular bacterial communities (Wright, Seed et al. 2007). Invasion promotes bacterial 
survival in the host through evasion of immune defenses and resistance to antimicrobial agents 
(Anderson, Martin et al. 2004).  
 
Similar to type 1 fimbriae, P fimbriae are synthesized through the chaperon-usher pathway 
(Sauer, Knight et al. 2000). They are more common among isolates that cause acute 
pyelonephritis and those that persist in the urinary tract leading to recurrent infections (Norinder, 
Luthje et al. 2011). P fimbriae bind glycosphingolipid residues commonly found on renal 
epithelial cells (Korhonen, Virkola et al. 1986). Given the coordinated expression of type 1 and P 
fimbria (Snyder, Haugen et al. 2005) and multi-step pathogenesis approach that bacteria employ 
in colonization of the urinary tract (Kaper, Nataro et al. 2004); it is likely that pyelonephritis 
strains express type 1 fimbria to colonize the urinary bladder and switch on P fimbria as they 
ascend and colonize the kidney (Blomfield 2001).  
 
     2.1.2 Iron acquisition 
Iron is essential for bacterial growth (Andrews, Robinson et al. 2003) but free iron concentrations 
are remarkably low in the host. Therefore, bacteria secret proteins that chelate iron with stronger 
affinity compared to host proteins (Fischbach, Lin et al. 2006). These iron-chelating proteins are 
referred to as siderophores and include enterobactin, aerobactin, salmochelin, and yersiniabactin. 
The siderophore-iron complexes anchor on outer membrane receptors like ChuA, IroN, IutA, 
Hma. From the surface, the complexes are actively transported to the cell cytoplasm and 
metabolized to release elemental iron (Braun and Braun 2002). There is redundancy in carriage 
of different siderophore receptors by pathogenic E. coli since triple catecholate receptor knock-
out mutants (fepA, iha and iroN) are not out-competed by wild type isolates (Garcia, Brumbaugh 
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et al. 2011). However, presence of iroN promotes biofilm formation (Magistro, Hoffmann et al. 
2015).  
 
     2.1.3 Biofilm formation  
Formation of multicellular bacterial communities (biofilm) is commonly found in persistent and 
chronic human infections (Costerton, Stewart et al. 1999). Biofilm can be found on both abiotic 
and biotic surfaces (Flemming and Wingender 2010). In the urinary tract, biofilm formation has 
been reported on catheters and epithelial cells (Anderson, Palermo et al. 2003, Wang, Lunsdorf et 
al. 2010). The process of biofilm formation involves reversible and irreversible binding to 
surfaces, production of an extracellular polymeric substance; formation of micro-colonies within 
the matrix and dispersal of filamentous bacteria from mature biofilms (Van Houdt and Michiels 
2005). Bacteria in a biofilm evade host immune responses, exchange genetic material and are 
more resistant to antimicrobial agents compared to planktonic bacteria (Hall-Stoodley, Costerton 
et al. 2004). Flagella, type 1 fimbriae, curli, cellulose, and Ag43 are involved in biofilm 
formation. 
 
Curli facilitates adhesion of E. coli to bladder epithelial cells and inter-bacterial adhesion 
(Kikuchi, Mizunoe et al. 2005). Equally, curli is a component of the extracellular polymeric 
substance in biofilm that protects them against LL-37-mediated killing of pathogenic bacteria 
(Kai-Larsen, Luthje et al. 2010). Cellulose is an inert component of the extracellular polymeric 
matrix that protects bacteria against host immune cells (Serra, Richter et al. 2013). The csgD 
gene regulates expression of both curli and cellulose but duo expression of curli and cellulose 
occurs in one third of UTI isolates (Brombacher, Baratto et al. 2006). However, E. coli that 
expresses both curli and cellulose form more biofilm compared to those expressing either curli or 
cellulose (Bokranz, Wang et al. 2005).  
Ag43 is a self-recognizing surface protein commonly found among E. coli of phylogenetic group 
B2 and D (Restieri, Garriss et al. 2007). It mediates auto-aggregation leading to micro-colony 
formation in bacterial biofilms (Schembri, Kjaergaard et al. 2003). Ag43 has five allelic variants; 
the pyelonephritis strain CFT073 carries two alleles (Ag43a and Ag43b) with 98% homology 
(Roche, McFadden et al. 2001). However, of the two alleles, Ag43a-expressing strains produce 
more biofilm compared to those expressing Ag43b (Ulett, Valle et al. 2007). 
 
2.2 Host defense factors 
The urinary tract remains sterile despite its proximity to the highly colonized gastro-intestinal 
tract (Chromek and Brauner 2008). Sterility is maintained by a combination of mechanical and 
chemical protective functions (Figure 3). In case pathogens overcome the mechanical barriers 
protecting the urinary tract, the host innate response broadens to include production of 
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antimicrobial peptides, chemokines and induction of apoptosis. Although these responses occur 
in parallel, they converge in function to eliminate invading pathogens. In addition, there are 
intricate mechanisms that prevent exaggeration of the inflammatory response and limit tissue 
damage (Abraham and Miao 2015).  
 
 
 
Figure 3: Host factors in the protection of the urinary tract against bacteria during infection: 1 - Urine 
flow, 2 – Anti-adherence factors [e.g. Tamm–Horsfall protein (THP)], 3 - Antimicrobial factors (e.g. 
nitric oxide, cathelicidin, defensins), 4 - Exfoliation of cells, 5 - Production of chemokines and 
cytokines, and 6 - Neutrophils. (Adopted from Chromek and Brauner 2008, Journal of Molecular 
Medicine) 
2.2.1 Urine flow and antibacterial proteins 
The bladder epithelium is adapted to regular filling and emptying and is impermeable to urine 
solutes (Walz, Haner et al. 1995). Urination washes out non-adherent bacteria and apoptotic 
cells. Voiding dysfunction like vesico-ureteric reflux increases the risk of developing UTI and 
may lead to renal damage thus further demonstrating the importance of bladder emptying 
(Swerkersson, Jodal et al. 2007). 
Antimicrobial proteins that protect the urinary tract include Tamm Horsfall protein (THP) and 
lipocalin 2. THP is constitutively produced by the ascending loop of Henle (Bachmann, Metzger 
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et al. 1990) and neutralizes E. coli type 1 fimbriae (Pak, Pu et al. 2001). Conversely, bacterial 
activation of α-intercalated cells in the kidney induces production of lipocalin 2 (Paragas, 
Kulkarni et al. 2014). Lipocalin-2 sequesters enterochelin – a bacterial siderophore and delivers 
the siderophore-iron complex to host cells for degradation (Miao and Abraham 2014). 
 
2.2.2 Host recognition of bacterial surface antigens 
Toll-like receptors (TLR) are proteins that recognize conserved pathogen-associated molecular 
patterns (PAMPs) (Fischer, Yamamoto et al. 2006). In humans, there are eleven TLRs of which 
TLR2, TLR4, TLR5 and TLR11 are present in the urinary tract (Kawai and Akira 2010). TLR 4 
in co-operation with CD14 recognizes LPS (Fischer, Yamamoto et al. 2006). Presence or 
absence of CD14 on uroepithelial cells is still debatable (Hedlund, Frendeus et al. 2001, 
Chromek, Stankowska et al. 2005), however, in cells that lack membrane-bound CD14, soluble 
CD14 plays a complementary role (Brenner, Zacheja et al. 2014).  
 
     2.2.3 Antimicrobial peptides  
In the last quarter of the 19th century, human tissues and body fluids were reported to have 
antimicrobial properties as reviewed by Skarnes (Skarnes and Watson 1957). However, the 
chemical mediators of antimicrobial action remained elusive until the 1990s (Agerberth, Gunne 
et al. 1995, Boman 1995). There are around a thousand antimicrobial peptides (AMP) in plants, 
animals and humans. Broadly classified into cathelicidin, defensins, S100 family of protein and 
RNase A superfamily (Wiesner and Vilcinskas 2010).  
 
Generally, epithelial and immune cells produce antimicrobial peptides that protect epithelial 
surfaces against microbial infections (Zasloff 2002). In pregnancy, antimicrobial peptides are 
abundant in amnion, vernix caseosa, vaginal secretions and the cervical mucus plug that 
separates the vaginal environment from the otherwise sterile uterine compartment (Kai-Larsen, 
Gudmundsson et al. 2014). 
 
     2.2.3.1 Cathelicidin 
LL-37 is the only cathelicidin antimicrobial peptide identified in humans. Apart from its 
antimicrobial properties, it is chemoattractant for neutrophils, monocytes and CD4 T cells 
(Tjabringa, Ninaber et al. 2006). Bladder epithelial cells constitutively produce LL-37 and its 
production markedly increases following a bacterial challenge (Chromek, Slamova et al. 2006). 
The antimicrobial properties of LL-37 include forming pores in the bacterial cell wall (Burton 
and Steel 2009) and inhibition of CsgA polymerization preventing curli formation and by 
extension biofilm (Kai-Larsen, Luthje et al. 2010).  
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2.2.3.2 Defensins 
 In humans, defensins are classified as α and β defensins (Selsted, Tang et al. 1993, Lehrer and 
Lu 2012). Alpha defensins are predominantly found in neutrophil azurophilic granules however, 
during acute inflammation, they may appear at epithelial surfaces possibly from infiltrating 
neutrophils (Doss, White et al. 2010). Conversely, β defensins are constitutively secreted by 
uroepithelial cells and their production increases following bacterial challenge (Hazlett and Wu 
2011). Although α defensins have definitive antimicrobial properties including pore-formation in 
bacterial cell walls, human β defensing 1 (HBD-1) has weak antimicrobial properties (Ganz and 
Lehrer 1995). It is likely that defensins act synergistically with LL-37 to protect the 
uroepithelium. 
 
2.2.3.3 Other important antimicrobial peptides in the urinary tract 
Apart from cathelicidin and defensins, antimicrobial peptides from both the RNase and S100 
families have been reported in the urinary tract. RNase 7 is produced by immune and epithelial 
cells including those lining the urinary tract (Spencer, Schwaderer et al. 2011). Its production 
increases during acute pyelonephritis (Spencer, Schwaderer et al. 2013). Psoriasin – a member of 
the S100 family of antimicrobial peptides – is produced by bladder epithelial cells (Celis, 
Rasmussen et al. 1996). It is bactericidal to E. coli and potentially protects the female genital 
tract from contamination by gastro-intestinal flora (Mildner, Stichenwirth et al. 2010). However, 
their role in the pathogenesis of UTI is still being explored. 
 
     2.2.4 Chemokines and cytokines 
Cytokines are multifunctional modulators of the host immune response functionally classified 
into pro-inflammatory, immune-regulatory and growth factors. They act through cognate 
receptors in a paracrine, autocrine and to some extent, in an endocrine manner (Spencer, 
Schwaderer et al. 2014). In the urinary tract, chemokines and cytokines are produced by 
epithelial and immune cells and mediate recruitment of neutrophils to the site of infection, 
induction of pyrexia, secretion of IgA and release of neutrophils from the bone marrow 
(Ragnarsdottir and Svanborg 2012). 
IL-8 is produced by uroepithelial cells in response to bacterial challenge and is necessary in 
neutrophil recruitment (Baggiolini, Walz et al. 1989, Godaly, Proudfoot et al. 1997). At the 
uroepithelial surface, neutrophils engulf and kill bacteria in phagosomes with reactive oxygen 
species, antimicrobial peptides or elastases (Witko-Sarsat, Rieu et al. 2000, Nauseef and 
Borregaard 2014).  
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     2.2.5 Apoptosis 
Apoptosis is programmed cell death that maintains tissues homeostasis; it can be initiated by 
pathological and physiological environmental factors (Kerr, Wyllie et al. 1972). Apoptosis of 
bladder epithelial cells markedly increases during urinary tract infections and E. coli may 
activate either the intrinsic or extrinsic pathways depending on the presence of virulence 
factors (Klumpp, Weiser et al. 2001, Klumpp, Rycyk et al. 2006). As part of the host innate 
response, apoptosis reduces bacterial load when detached cells are washed out during urination. 
However, it exposes deeper layers of bladder epithelial cells in which E. coli can establish 
quiescent intracellular communities. Quiescent intracellular bacterial communities are 
associated with recurrent urinary tract infection (Schwartz, Chen et al. 2011).  
 
     2.2.6 Vitamin D 
Vitamin D is a fat-soluble vitamin that is synthesized under the skin. Photolytic conversion of 7-
dehydrocholestrol leads to formation of previtamin D3 that is transported to the liver. 
Cytochrome P450 enzymes hydroxylate previtamin D3 to 25OHD3, circulating 25OHD3 can be 
converted to the active hormone 1,25OH2D3 by renal 1α-hydroxylase (Figure 4). However, at 
epithelial surfaces and in immune cells, 25OHD3 can be converted into the active hormone and 
activates vitamin D-regulated genes (Adams and Hewison 2010). Most of the vitamin D is 
synthesized from the skin, alternative dietary sources include fatty fish or fortified foods. 
Optimal vitamin D during pregnancy is required in the deposition of the fetal skeleton while its 
deficiency is associated with low birth weight, small for gestational age and to some extent 
pregnancy-induced hypertension (Wei 2014, Chen, Fu et al. 2015).  
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Figure 4: Photolytic conversion of 7-dehydrocholesterol occurs under the skin leading to 
formation of vitamin D3 – a substrate of 25-hydroxylase enzymes in the liver. It is converted into 
25-OHD3 (the main circulating form of vitamin D). Apart from renal 1α-hydroxylase, bladder 
and innate immune cells are able to convert 25-OHD3 into 1,25 (OH)2D3 the active form of 
vitamin D (Hertting, Holm et al. 2010, Moran-Auth, Penna-Martinez et al. 2013). 1,25 (OH)2D3 
induces production of antimicrobial peptides when coupled with vitamin D receptor. 
 
Therapeutic effects of vitamin D were recognized in the late 19th Century leading to a Nobel 
prize in Medicine award to Niels Ryberg Finsen in 1903 (nobelprize.org). Recently, vitamin D 
was reported to modulate innate and adaptive immune responses and influence disease outcomes 
(Olliver, Spelmink et al. 2013, Chun, Liu et al. 2014). Vitamin D deficiency rickets has 
rebounded even in areas where vitamin D supplementation is routinely done (Singleton, Lescher 
et al. 2015, Wheeler, Dickson et al. 2015). Globally, dark-skinned people living in temperate 
climates (van der Meer, Karamali et al. 2006), the elderly and those living in the tropics but 
extensively cover their bodies to allow adequate synthesis of vitamin D (Lips 2010) are at 
increased of vitamin D deficiency.  
 
Vitamin D induces expression of both CAMP and DEFB4 genes that have vitamin D response 
elements in their promoter regions (Gombart, Borregaard et al. 2005, Liu, Schenk et al. 2009). In 
the urinary tract, vitamin D supplementation increases production of LL-37 during an infection 
challenge, potentially defending the uroepithelium against pathogenic bacteria (Hertting, Holm et 
al. 2010). Therefore, pregnant women together with their unborn babies could potentially benefit 
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from optimal serum vitamin D levels. Where vitamin D deficiency is likely to occur due to 
inadequate skin exposure or lack of vitamin D fortified foods or skin pigmentation; 
supplementation with vitamin D could be an alternative. 
 
     2.2.7 Diagnosis of UTI in pregnancy  
Clinical diagnosis of UTI and initiation of antimicrobial therapy is cost-effective among adult 
non-pregnant women where the causative organisms and their antimicrobial susceptibility pattern 
are known (Fenwick, Briggs et al. 2000, Bent, Nallamothu et al. 2002). However, during 
pregnancy, symptoms are largely non-specific for UTI therefore, clinical diagnosis may be 
overestimating the prevalence. Bacteriological culture is the golden standard in the diagnosis of 
UTI but is not universally available. Low-cost alternative diagnostic tests like nitrite, leucocyte 
esterase, microscopy and dipslide were evaluated in this thesis.  
 
     2.2.8 Management of UTI in pregnancy 
Antibiotic use during pregnancy may have side effects on the fetus (Bisschop, Merkus et al. 
1985, Kenyon, Pike et al. 2008). In Uganda, cotrimoxazole and amoxicillin are recommended in 
the management of lower UTI while ciprofloxacin is reserved for upper UTI (Uganda 2012). 
However, there is increasing resistance of uropathogens to cotrimoxazole and amoxicillin 
(Ramos, Dzung et al. 2011). Additionally, cotrimoxazole use is contra-indicated in the first 
trimester of gestation because it doubles the risk for neural tube defects in the newborn 
(Hernandez-Diaz, Werler et al. 2001). Ciprofloxacin crosses the placenta and is associated with 
arthropathy, restricting its use during pregnancy (Giamarellou, Kolokythas et al. 1989).  
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    3 AIMS OF THE THESIS 
The overall aim of this project was to investigate UTI in pregnancy with special emphases on 
diagnoses, bacterial virulence factors and prevention of infection.  
The specific aims were: 
1. To investigate the susceptibility pattern and virulence factors of uropathogenic E. coli 
isolates from pregnant women in Uganda and in comparison Vietnam and Sweden. 
2. To evaluate low-cost, simple diagnostic approaches to diagnose UTI in pregnancy. 
3. To determine the impact of vitamin D on innate immune responses to E. coli during UTI in 
pregnancy.  
4. To evaluate the effect of the phyto-estrogenic herb Labisia pumila var. alata (LPva) on the 
host-pathogen interaction in vitro. 
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4 PARTICIPANTS AND METHODS 
4.1 PARTICIPANTS 
The first three papers of this thesis used material collected from human participants and were 
approved by the local ethics committees in Kampala, Uganda, Hanoi, Vietnam, and Stockholm, 
Sweden.  
In paper I, 148 pregnant women with E.coli UTI were recruited. Study participants were 
attending antenatal clinics at Mulago Hospital, Kampala (n = 56), the National Hospital of 
Obstetrics and Gynecology, Hanoi, (n = 42), and Karolinska University Hospital, Stockholm (n 
= 50). They were between 17 and 48 years old and their gestational ages ranged from 4 to 40 
weeks. Only those who had not used antibiotics two weeks prior to screening were included in 
the study. Age-matched non-pregnant women with E.coli UTI attending clinics in the 
Stockholm area, Sweden served as controls (n =50). The antibiotic susceptibility pattern and 
virulence factors of all isolates were investigated. 
In paper II, 2 562 participants were altogether recruited; 1 621 were pregnant women with or 
without UTI symptoms attending routine antenatal care in Mulago hospital. The rest of the 
participants (n=941) were outpatients, 472 general outpatients from Mulago and 469 were non-
pregnant women who were attending clinics in the Stockholm area.  
In paper III, variation of serum vitamin D levels in pregnancy and its impact on innate immune 
responses during UPEC infection were investigated. Blood samples were collected from 32 
pregnant women attending the antenatal clinic at Mulago Hospital, Kampala, during the 1st, 2nd 
and 3rd trimester; further, from 16 of these women, samples were collected after delivery. Age-
matched never pregnant women (n = 25) served as controls. The median age of pregnant and 
never pregnant women was 23 years. In an interviewer-administered questionnaire during their 
first visit, pregnant women were asked about consumption of vitamin D rich or vitamin D-
fortified foods over the previous 24 hours.   
 
    4.2 SAMPLE COLLECTION 
In paper I, and II, midstream urine was collected in sterile containers and either analyzed at the 
point-of-care or delivered to the microbiology laboratory within one hour. 
In paper III, blood was collected in vacutainer tubes loaded with a gel separator (Greiner bio-one) 
and centrifuged at 1500 × g for 15 minutes to separate serum that was aliquoted and stored in 
light-protected containers at – 80oC until analysis 
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4.2.1 Urine analyses 
In paper I, urine cultures were done following protocols at the respective sample collection sites. 
Overall, primary cultures were done on Uriselect agar (Bio-Rad Laboratories) in Hanoi, blood 
and MacConkey agar (Bio-Rad Laboratories) in Kampala, while in Stockholm, primary cultures 
were done on blood and CHROMagar (bioMérieux, Marcy l’Etoile). They were incubated at 
37oC overnight. Significant bacteriuria for women with cystitis was > 103 CFU/ml of E. coli,  
> 104 CFU/ml of Gram negative or >105 CFU of Gram positive bacteria while > 105 CFU/ml of 
urine in the absence of symptoms was classified as ABU.  
Species identification was done at the respective sites as well as at Karolinska University 
Hospital. 
In paper II, urine samples were analyzed using Multistix 10SG® (Siemens, Munich, Germany), 
microscopy, Uricult Trio® (Orion Diagnostica, Espoo, Finland) and urine culture.  
Multistix 10SG were used to detect presence of leucocytes and nitrite following the 
manufacturer’s instructions. To enumerate microscopic leucocyturia, approximately 3-5 
milliliters aliquot of well mixed urine were centrifuged at 450 × g for 5 minutes, the supernatant 
was decanted and the pellet was suspended in about 1 ml of urine. Fifteen microliters were 
transferred on a glass slide and covered with a coverslip. Ten fields were examined at 40x 
magnification under a microscope (Olympus Ch20, Olympus, USA) and > 10 leucocytes per 
high power field was considered significant pyuria.  
Uricult Trio® (Orion Diagnostica, Espoo, Finland) is a dipslide method that has CLED agar 
covering one side of the slide and half of both MacConkey agar and E. coli-specific agar on the 
other side. It was inoculated with midstream urine and incubated overnight to determine bacterial 
growth together with lactose fermentation. CFU count and lactose fermentation were done on 
CLED agar, while detection of beta-glucuronidase-producing bacteria was done on the E. coli-
specific agar.  
 
4.2.2 Protein assay by ELISA 
In paper III, serum was analyzed for LL-37 (Hycult), hBD-2 (Alpha Diagnostics), IL-8 (R&D 
systems) and soluble CD14 (R&D systems) using ELISA following the respective 
manufacturer’s protocols. Serum 25 OHD was determined using an antibody-based 
chemiluminescence assay (Diasorin).  
 
4.3 IN VITRO EXPERIMENTS 
 
4.3.1 Labisia pumila var alata 
LPva is a medicinal herb that belongs to the family Myrsinaceae. It is widely used by women in 
Malaysia (Stone 1988) and was found to have phyto-estrogenic effects (Fazliana, Gu et al. 2012). 
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In our experiments, a water extract (Yusoff and Mohamud 2011) from a certified Good 
Manufacturing Practices herbal facility was used. The powder was re-constituted in deionized 
water and filter-sterilized to make a stock solution. It was diluted in cell culture medium to 10 
µg/ml, 100 µg/ml and 1000 µg/ml for in vitro experiments (paper IV). 
 
4.3.2 Bacteria 
Species identification of clinical isolates 
Clinical E. coli isolates were evaluated for their antimicrobial susceptibility and virulence factors. 
In paper I, and paper II, species confirmation of clinical E. coli isolates was performed using 
Vitek 2 Gram negative identification card for fermenting and non-fermenting bacteria 
(bioMérieux, Marcy l’Etoile, France). Pure colonies were prepared in 0.5% NaCl and the 
turbidity was adjusted between 0.50 and 0.63 McFarland units.  
In paper II, in addition to Vitek 2 identification of clinical E. coli isolates, MALDI-TOF mass 
spectrometry (Bruker, Daltonik, GmbH, Bremen, Germany) was used following the 
manufacturer’s instructions. Briefly, pure colonies were inoculated on the metallic MALDI target 
plates and overlaid with MALDI matrix; they were left to dry at room temperature and loaded for 
identification.   
 
Antibiotic susceptibility testing 
Antimicrobial susceptibility of clinical isolates to ampicillin, amoxicillin-clavulanic acid, 
ciprofloxacin, gentamicin, trimethoprim and cephalexin was also done using Vitek 2 (AST-
N106).  Further, the disc-diffusion method was used to test susceptibility to cefotaxime, 
ceftibutin, ceftazidime, piperacillin, imipenem and meropenem. 
 
E. coli CFT073  
In paper I, III & IV, the pyelonephritis E. coli strain CFT073 was used either in infection 
experiments or as a positive control for virulence factors. CFT073 was originally isolated from 
urine and blood of a patient with pyelonephritis (Mobley, Green et al. 1990) and expresses both 
type 1 and P fimbriae (Mobley, Jarvis et al. 1993). It also expresses toxins like secreted 
autotransporter toxin (Nichols, Totsika et al. 2016) and hemolysin (Mobley, Green et al. 1990), 
iron acquisition systems like iroN, chuA, iutA (Mills, Meysick et al. 2000, Alteri and Mobley 
2007), and forms biofilm (Ulett, Valle et al. 2007).  
 
4.3.3 Cell lines 
To mimic the host response to E. coli infection, human bladder cancer (T24, 5637) and 
telomerase-immortalized urothelial cells (TERT-NHUC) were used. T24 and 5637 cells were 
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grown in McCoy’s and RPMI 1640 medium respectively, supplemented with 10% fetal bovine 
serum while TERT-NHUC cells were maintained in Epilife medium with 60µM calcium and 
human keratinocyte growth supplement (Gibco, Carlsbad, CA, USA). In all cell culture 
experiments, incubation was done at 37°C in a humidified chamber with 5% CO2. T24 cells 
were used in paper I, III and IV; TERT-NHUC in paper III and 5637 in paper IV.  
 
6.3.2.1 Studies on type 1 fimbriae (paper I and IV) 
To investigate the expression of type 1 fimbriae, baker´s yeast, Saccharomyces cerevisiae was 
used to test the specificity of the interaction (Korhonen, Leffler et al. 1981). Bacteria were grown 
overnight on LB agar without salt and suspended in PBS to a final concentration of 1010 CFU/ml. 
Equal parts of bacteria and 3% Saccharomyces cerevisiae in PBS were mixed and observed for 
agglutination. The specificity of the test was confirmed by adding 5% mannose in PBS. In Paper 
I, expression of type 1 fimbriae by clinical E. coli isolates was investigated and in paper IV the 
interaction of LPva extract with E. coli CFT073 type 1 fimbriae was determined.   
 
4.3.2.2 Curli, cellulose and detection of biofilm  
Curli and/or cellulose expressing E. coli have characteristic morphotypes on Congo red and 
Calcofluor agar (Bokranz, Wang et al. 2005). Bacteria were streaked on the respective plates and 
incubated at 37°C; the morphotypes were determined at 24 h and 48 h on Congo red and 
Calcoflour agar respectively. On Congo red plates, colonies that are curli and cellulose positive 
appear red; curli negative, cellulose positive bacteria appear pink while curli positive, cellulose 
negative bacteria appear brown and colonies of bacteria that are negative for both curli and 
cellulose appear white. On Calcofluor agar, colonies of cellulose expressing E. coli fluoresce on 
exposure to UV light. In paper I, curli and cellulose expression by clinical isolates was 
determined using Congo red and Calcofluor agar with appropriate controls.  
Biofilm formation was determined by the microtiter plate method (Wakimoto, Nishi et al. 
2004) in paper I. Briefly; bacteria were grown overnight on LB agar without salt.  Colonies 
were suspended in PBS and centrifuged at 300 × g for 10 minutes to remove aggregates. The 
supernatants were adjusted to 108 CFU/ml by spectrophotometry; a 1:100 dilution was made in 
LB broth without salt and 200 µl aliquots were pipetted into a 96-well plate (Costar, Corning). 
The plate was incubated at 37°C for 24 h, the supernatant containing planktonic bacteria was 
aspirated and discarded, wells were washed with PBS, air dried and stained with crystal violet. 
The crystal violet was solubilized in acetone-alcohol and the optical density determined at 550 
nm by spectrophotometry to quantify the amount of biofilm formed. 
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4.3.2.3 Inhibition of bacterial growth 
The agar diffusion sensitivity assay was used to test the antimicrobial activity of human serum 
(paper III) and LPva (paper IV). Bacteria were grown to mid logarithmic phase and embedded in 
a thin layer of LB broth with 1% agarose. The molten agar was poured into petri dishes and left 
to solidify at room temperature for 30 minutes; 3 mm diameter wells were made in the agar to 
which 3 µl of test substance were added and incubated overnight.  Antimicrobial potential of the 
tested substance was determined by measuring the diameter of the inhibition zone around the 
well. 
In paper III, inhibition of UPEC CFT073 growth was tested against serum containing low (<50 
nmol/L) or high (>80 nmol/L) 25(OH) D.   
In paper IV, the antimicrobial potential of LPva was determined against E.coli 25922, P. 
mirabilis 29906, P. aeruginosa 27853, S. aureus 29213, S. saprophyticus 15305, and C. albicans 
90028.  
 
4.3.2.4 Infection experiments  
Urothelial cells were infected with 106 CFU/ml of either clinical E. coli isolates (paper I) or E. 
coli CFT073 (paper III & IV) for different time periods. Total mRNA was extracted for gene 
expression studies (paper IV), protein quantification was done in cell lysates by Western blot 
(paper IV) and in supernatants by ELISA (paper III).  
 
4.3.2.5 Bacterial adhesion and invasion of urothelial cells 
In paper I, different clinical E. coli isolates were tested for adhesion and invasion of T24 cells 
while in paper IV, the influence of LPva on adhesion and invasion of T24 and 5637 cells by E. 
coli CFT073 was studied.  
Cells were infected and incubated for 30 minutes, non-adherent bacteria were washed away with 
PBS. The cells were lysed with 1%Triton X-100 in PBS. The lysates were serially diluted in PBS 
and plated on blood agar and incubated overnight at 37oC to determine the CFU of cell-
associated bacteria.  
To determine the concentration of intracellular bacteria, the process was as described above 
followed with a gentamycin protection assay for additional 90 minutes to allow bacteria to 
invade cells. Thereafter, cells were lysed, serially diluted, incubated on blood agar overnight 
and CFU count was used to quantify intracellular bacteria. 
 
4.3.2.6 Gene amplification by PCR 
Gene amplification was done for bacterial DNA to study virulence factors and human urothelial 
cells for expression of innate response genes. Bacterial DNA was extracted using a modified 
boiling method (paper I). It was amplified by multiplex PCR to determine phylogenetic groups 
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(Clermont, Bonacorsi et al. 2000) and uniplex PCR was done for virulence factor genes. Both 
multiplex and uniplex PCR products were separated by gel electrophoresis; amplicons were 
stained with ethidium bromide or GelRed to visualize specific sizes corresponding to the 
respective virulence factor genes (Mothershed and Whitney 2006). In paper I, phylogenetic 
groups of clinical isolates and E. coli virulence factors that include flu, fluACFT073, fluBCFT073, 
iroNE.coli, and tcpC were investigated.  
In paper III & IV, total RNA was extracted from urothelial cells using a spin column technique. 
Complementary DNA (cDNA) was synthesized using standard procedures and following 
manufacturer’s instructions for the respective kits. CAMP, caveolin-1 and β-1 integrin were 
amplified by RT-PCR. GAPDH was used as the internal reference and relative change in gene 
expression were measured using the 2-ΔΔCt method (Schmittgen and Livak 2008). In paper III, the 
effect of human serum on IL-8, CD14 mRNA; in paper IV the effect of LPva on LL-37, hBD-2, 
caveolin-1 and β-1 integrin mRNA expression were determined.  
 
4.3.2.7 Protein assay by Western blot 
After infecting cells following LPva treatment (paper IV), they were washed with ice cold PBS 
and lysed with lysis buffer that includes protease inhibitors (Sigma-Aldrich) and sonicated.  The 
protein concentration was determined using the bicinchoninic acid (BCA) protein assay kit and 
samples were adjusted to equal concentrations and boiled in Laemmli buffer with or without β-
mercaptoethanol for caveolin-1 and β-1 integrin respectively.  
Samples were run on SDS-PAGE from Bio-Rad Laboratories and transferred to a 0.45 µm 
Invitrolon PVDF membrane – Invitrogen, that was then blocked for one hour with 5% milk in 
Tris-buffered saline with 0.05% Tween 20 at room temperature. The membrane was incubated 
with primary antibodies goat anti-caveolin-1 and mouse anti-β-1 integrin at 4oC overnight; 
followed with HRP-labelled secondary anti-goat antibody for caveolin-1 and anti-mouse 
antibody for β-1 integrin. Super signal Pico Kit (Pierce, Thermo Scientific, Waltham, MA, USA) 
was used to visualize the bands and relative protein quantities were determined by measuring 
band intensities with Image J. As controls, membranes were stripped and re-probed with anti-
GAPDH antibodies.  
  
4.3.2.8 Apoptosis assay 
To assess the effect of LPva on apoptosis of infected and non-infected urothelial cells, T24 cells 
were grown on coverslips for 24 h and treated with LPva for 6, 24 or 72 h. They were infected 
with E. coli CFT073 for 60 minutes and stained for apoptotic changes at 6 or 24 h (paper IV). 
Non-treated non-infected cells served as controls. Briefly, cells were stained with Annexin V 
Fluos and In Situ Cell Death Detection Kit (Roche Applied Science, Penzberg, Germany); 4’, 6-
diamidine-2 phenylindole dihydrochloride (DAPI, Sigma Aldrich) was used to stain the nucleus. 
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Annexin V stains exteriorized phosphatidylserine on the cytoplasmic membrane – a marker of 
early apoptotic changes. Propidium iodide stains DNA where cytoplasmic membrane integrity is 
compromised – as may occur during necrosis. Apoptosis was also investigated using TUNEL 
assay; cells were fixed with 2% formaldehyde in PBS, permeabilised with ice-cold 70% ethanol 
and then incubated with TdT buffers. Cells were mounted in Prolong Gold anti-fade reagent 
(Invitrogen, Carlsbad, CA, USA) and visualized under Leitz-Leica DMRB fluorescent 
microscope.  
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5 RESULTS 
 
5.1 UROPATHOGENIC E. COLI ISOLATES FROM PREGNANT WOMEN IN 
DIFFERENT COUNTRIES (PAPER I)  
We sought to compare the virulence factors and antimicrobial susceptibility pattern of E. coli 
causing UTI in low, middle and high-income countries. Isolates were collected from pregnant 
women in Uganda, Vietnam and Sweden to represent the different income categories and where 
the accessibility of antibiotic differs. From Sweden, E. coli from non-pregnant women of 
reproductive age with UTI served as controls.   
 
E. coli isolates from pregnant and non-pregnant women from Sweden and those from Vietnam 
belonged to phylogenetic group B2 while more Ugandan isolates belonged to phylogenetic group 
B1. This finding prompted us to investigate differences in the ability of B1 and B2 isolates to 
cause infection. We therefore investigated the initial step of the infection process and evaluated 
the bacteria´s ability to adhere and invade urothelial cells and form biofilm. Isolates belonging to 
phylogenetic group B1 adhered to and invaded urothelial cells as efficiently as those of 
phylogenetic group B2. However, those belonging to phylogenetic group B2 produced more 
biofilm.  
 
The fluA gene is implicated in bacterial auto-aggregation leading to formation of biofilm (Ulett, 
Valle et al. 2007). It was more prevalent among isolates belonging to phylogenetic groups B2 
and D compared to B1 and A in Vietnam (P=0.0004) and Uganda (P=0.0001); overall, more 
Ugandan isolates carried the fluA gene.  
 
We further observed a strong correlation between the genes tcpC and iroNE coli and the 
phylogenetic group B2. While tcpC mediates the ability to modulate host innate immune 
response, iroNE.coli encodes a catecholate siderophore. The prevalence of both genes was lower 
among Ugandan isolates compared to those from Sweden and Vietnam.  
Resistance to ampicillin in Uganda, Vietnam and Sweden was 75%, 83% and 22% Sweden 
respectively. Correspondingly, we observed a high prevalence of ESBL-producing E. coli in 
Uganda (14%) and Vietnam (7%) compared to Sweden (2%). There was a two-fold high 
prevalence of MDR compared to ESBL.  
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5.2 ANTIBIOTIC OVERCONSUMPTION IN PREGNANT WOMEN WITH URINARY 
TRACT SYMPTOMS IN UGANDA (PAPER II) 
Clinical diagnosis and antibiotic treatment of patients, including pregnant women, with 
symptoms of UTI is common practice in developing countries. This is largely due to limited 
access to diagnostic services. However, during pregnancy, UTI symptoms especially at advanced 
gestational age are largely unreliable indicators of infection. But that only 4 % of pregnant 
women with UTI symptoms had culture verified bacteriuria and 96% received unnecessary 
antibiotics was a surprise.  We therefore evaluated simple diagnostic tests with potential for use 
by midlevel health workers in outpatient clinics to reduce antibiotic consumption. The diagnostic 
tests included nitrite, leucocyte esterase, microscopy and dipslide.  
  
Nitrite, leucocyte esterase and leucocyturia when used alone had low accuracy in diagnosis of 
UTI and ABU during pregnancy. The sensitivity of the combined nitrite and leucocyte esterase 
was poor. Urine microscopy was equally of low diagnostic value. We found low correlation 
between leucocyturia and leucocyte esterase (38%). Overall, nitrite and leucocyte esterase had 
low sensitivity and high specificity. 
 
Dipslide, a simplified culture method mainly used in the diagnosis E. coli UTI was evaluated.  
Microbiologically non-trained medical staff, like gynaecologist and nurses could accurately 
detect E. coli; accuracy improved cumulatively. Although, E. coli was accurately detected, 
growth of other Gram-negative bacteria was overestimated. 
 
5.3 THE IMPACT OF VITAMIN D ON THE INNATE IMMUNE RESPONSE TO 
UROPATHOGENIC ESCHERICHIA COLI DURING PREGNANCY (PAPER III) 
Vitamin D is important during pregnancy both to the mother and the baby, with possible long-
term effects on the child among pregnant women with vitamin D deficiency. Further it has been 
shown that it also plays a role in adaptive as well as innate immunity. The major source of 
vitamin D is UV radiation-mediated synthesis from the skin.  However, this effect is attenuated 
by dark skin pigmentation and in persons who are covered. We investigated the role of vitamin 
D, vitamin D-regulated antimicrobial peptides - LL-37, hBD-2; sCD14 and IL-8 in the 
pathogenesis of UTI in vivo and in vitro.  
Serum vitamin D levels increased with gestational age and were higher in the third compared to 
the first trimester (P<0.01) and compared to never pregnant women. Further, multigravidae had 
higher vitamin D levels compared to prime gravidae.  
 
Vitamin D can induce cathelicidin, LL-37 and hBD2 by binding to the vitamin D responsive 
element (VDRE) of the promoter region (Gombart, Borregaard et al. 2005). The human 
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cathelicidin, LL-37 increased significantly (P<0.001) with advancing gestational age. Moreover, 
in line with the increase of LL-37, the antimicrobial activity of serum increased with gestational 
age. In the current study, we did not observe any increase of hBD2.  
 
We observed lower IL-8 levels in the third compared to first trimester and also versus after 
delivery and in serum from never pregnant women, sCD14 did not change. In an in vitro model 
to mimic UTI, uroepithelial cells treated with serum containing >80 nmol/L of vitamin D 
expressed significantly lower levels of IL-8 at mRNA (P<0.05) and protein (P<0.01) levels 
compared to those treated with serum containing <50 nmol/L of vitamin D. To rule out the 
possibility of other serum factors influencing our results, uroepithelial cells were treated with 
synthetic vitamin D. Interestingly; vitamin D suppressed IL-8 production in a dose-dependent 
manner.  
 
       5.4 LABISIA PUMILA VAR. ALATA REDUCES BACTERIAL LOAD BY INDUCING 
UROEPITHELIAL CELL APOPOTOSIS (PAPER IV) 
Labisia pumila var. alata (LPva) is a herb commonly used in Malaysia to treat urogenital 
diseases. Due to its phytoestrogenic effects we assumed that it also had effect against UTI and 
therefore investigated its in vitro effect on E. coli infected uroepithelial cells.  
 
We demonstrate that LPva induced apoptosis in a dose-dependent manner and that apoptosis 
was associated with increased caveolin-1 expression both on the mRNA and protein levels. 
Further, we demonstrate that β-1 integrin decreased and although bacterial adhesion was not 
affected a clear down-regulation of invasion was noted. No direct antibacterial effect was 
observed, nor did LPva induce antimicrobial peptides.  
LPva seems to have both an apoptotic activity, clearing infecting bacteria at the same time 
protecting the deeper tissue layers by down-regulating β-1 integrin and bacterial invasion.  
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6 DISCUSSION 
Pregnant women are more prone to UTI compared to their non-pregnant counterparts and kidney 
involvement may be associated with poor-pregnancy outcomes. Due to limited access to 
microbiological services in developing countries, antibiotics are commonly dispensed for UTI 
based on clinical symptoms. Given the rising burden of antimicrobial resistance globally, 
alternatives to antimicrobial agents require further inquiry. This thesis compared the virulence 
characteristics and antimicrobial susceptibility of E. coli causing UTI in pregnant women in 
Uganda, Vietnam to those from Sweden (paper I), evaluated leucocyte esterase, nitrite, dipslide 
and microscopy against urine culture in the diagnosis of UTI (paper II). The roles of IL-8, 
sCD14, vitamin D, vitamin D-regulated antimicrobial peptides (paper III) and LPva on the 
pathogenesis of UTI (paper IV) were investigated. 
 
Pathogenic E. coli compared to commensals express more adhesins, toxins and immune evasion 
mechanisms (Welch, Burland et al. 2002). It is postulated that presence of virulence factors 
enable ExPEC to harmlessly colonize the gut of warm-blooded animals from which it causes 
disease in the urinary tract, lungs or meninges (Diard, Garry et al. 2010). There is a 
preponderance of capsule, iron-acquisition and pathogenicity islands in E. coli belonging to 
phylogenetic group B2 (Johnson and Stell 2000). However, presence of a high number of 
virulence factors comes with a fitness cost since there is an inverse relationship between 
virulence factor score and antibiotic resistance (Moreno, Prats et al. 2006). Nonetheless, a 
proportion of isolates from phylogenetic groups D, B1 and A that possess the requisite virulent 
factors are able to cause disease (Kudinha, Johnson et al. 2013). Among patients with voiding 
dysfunction or vesico-ureteric reflux, less virulent strains of E. coli efficiently colonize the 
urinary tract as would virulent strains in patients without abnormalities (Johnson, Roberts et al. 
1987). Pregnancy-related voiding dysfunction and vesico-ureteric reflux is partly due to the 
increasing size of the uterus (Law and Fiadjoe 2012). Similar to other investigators, in paper I, 
majority of UPEC in pregnant women from Vietnam and Sweden belonged to phylogenetic 
group B2 and D (Picard, Garcia et al. 1999, Clermont, Bonacorsi et al. 2000). Although more 
isolates from Uganda belonged to phylogenetic group B1, they didn’t differ in their virulence 
compared to those of phylogenetic group B2 in terms of adhesion and invasion but formed less 
biofilm. UPEC form biofilm, modify host response following TLR4 activation and sequester iron 
at low concentrations as part of the survival mechanisms in the host (Cirl, Wieser et al. 2008). 
TcpC hinders recruitment of adaptor proteins to the cytoplasmic domain of Toll/Interleukin 1 
receptor potentially modifying host cytokine response and promoting pathogen survival. IroNE coli 
apart from being a siderophore receptor, it also promotes biofilm formation (Magistro, Hoffmann 
et al. 2015). Given the dominant presence of virulence factors among E. coli isolates of 
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phylogenetic group B2 (Johnson, Owens et al. 2005), we found a strong correlation between 
presence of both tcpC and iroNE coli with phylogenetic group B2.  
 
The high prevalence of antibiotic resistance observed among Ugandan isolates compared to those 
from Sweden may in part be explained by the high frequency of phylogenetic group B1 (Cooke, 
Smith et al. 2010). Conversely, antibiotic consumption exerts selective pressure on bacteria 
leading to emergence of resistant strains (Andersson and Hughes 2010). A correlation between 
antibiotic consumption and prevalence of drug resistance has been established (Bergman, Nyberg 
et al. 2009). Moreover, in both Uganda and Vietnam antibiotics are overused, occasionally sub-
optimally and can be dispensed over-the-counter (Mukonzo, Namuwenge et al. 2013, Nguyen, 
Thi Do et al. 2013). Antibiotic overconsumption may contribute to the differences in drug 
resistance between Sweden and Uganda or Vietnam.  
 
UTI is the most common indication for antibiotic prescription during pregnancy (Petersen, 
Gilbert et al. 2010). Notwithstanding the therapeutic effects of antibiotics in UTI, their use in 
pregnancy is associated with untoward long-term effects in childhood like cerebral palsy and 
asthma (Kenyon, Pike et al. 2008, Metsala, Lundqvist et al. 2015). Generally, 4% - 10% of 
pregnant women develop UTI (Foxman 2002) while a slightly higher prevalence is reported in 
some parts of Africa (Hamdan, Ziad et al. 2011, Alemu, Moges et al. 2012), in paper II, the 
prevalence of significant bacteriuria among pregnant women with UTI symptoms was 4%. 
Because antibiotics were dispensed in lieu of presence of symptoms, 96% of pregnant women 
with UTI symptoms received them unnecessarily. We report massive antibiotic misuse where 
clinical rather than bacteriological culture is used in the diagnosis of UTI.  
Nitrofurantoin remains largely effective against uropathogens and recommended as alternative 
first line therapy where cotrimoxazole resistance is high (Nicolle 2003, Komp Lindgren, 
Klockars et al. 2015). Its use is associated with heamolytic anaemia in patients with glucose-6-
phosphate dehydrogenase (G6PD) deficiency (Youngster, Arcavi et al. 2010).  
Cephalosporin antibiotics are safe in pregnancy but the current magnitude of antimicrobial 
resistance and its potential to increase poses serious global health challenges (Levy and 
Marshall 2004).  
 
Antibiotic resistance is driven by over-use, procuring antibiotics over-the-counter and 
contamination of water sources (Nordmann, Naas et al. 2011). The factors that drive 
antimicrobial resistance are rife in Africa and Asia; correspondingly, they carry a higher 
burden of antibiotic resistance compared to developed countries (Rosenthal, Bijie et al. 2012).  
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Empiric management of uncomplicated UTI in women is a cost-effective intervention (Barry, 
Ebell et al. 1997, Le and Miller 2001). Especially when more than 80% of the most prevalent 
uropathogen is susceptible to the recommended antibiotic. However, in Uganda, 72% and 66% 
of E. coli were resistant to trimethoprim and amoxicillin respectively. Therefore, pregnant 
women with UTI symptoms suffer a double tragedy; 96% receive antibiotics unnecessarily while 
4% with UTI get ineffective antimicrobial agents. 
 
In paper II, we investigated the diagnostic accuracy of nitrite, leucocyte esterase, dipslide and 
microscopy among participants with or without lower UTI symptoms. Nurses, gynaecologist and 
clinical microbiologist evaluated nitrite, leucocyte esterase and dipslide in different study settings 
and participants. Negative nitrite and leucocyte esterase have high accuracy in ruling out UTI 
among pregnant women (Deville, Yzermans et al. 2004) however, their sensitivity and specificity 
are variable in different patient groups (Williams, Macaskill et al. 2010). It is therefore likely that 
they may have limited application in general outpatient settings. Surprisingly, the nitrite test was 
negative among pregnant women with or without UTI symptoms while the sensitivity of the 
leucocyte esterase was very low to be clinically useful. Microscopic pyuria has been traditionally 
used in urinalysis to diagnose UTI. Despite improvements like automation (Sterry-Blunt, K et al. 
2015), urine microscopy remains a poor surrogate marker of UTI (Kupelian, Horsley et al. 2013). 
 
There are conflicting reports about the clinical usefulness of dipslide in screening for ABU and 
diagnosis of UTI (Greeff, Jeffery et al. 2002, Anacleto, Resontoc et al. 2009). However, in 87% 
and 79% of urine samples read by the gynaecologist and nurses respectively, E. coli was 
correctly identified. The duration of training and expertise accumulated by readers trained-on-job 
influenced the accuracy of dipslide. Dipslide could potentially bridge the diagnostic gap in 
resource-limited settings but requires training and supervision of frontline medical workers to 
ensure accurate diagnosis. 
 
Vitamin D is one of the main regulators of calcium homeostasis but it also modulates both innate 
and adaptive immune responses (Hewison 2010). There are few dietary sources of vitamin D 
with majority being synthesized by the skin after exposure to UVB light (Holick 1996). 
Therefore, skin pigmentation, use of sunscreens, residence in temperate climates and 
consumption of vitamin D-fortified foods are factors that influence serum vitamin D levels 
(Webb, Kline et al. 1988, Martin, Gowda et al. 2016). During pregnancy, the fetus entirely relies 
on the mother for both calcium and vitamin D and there is strong correlation between maternal 
and cord vitamin D levels (Hanson, Anderson-Berry et al. 2016). Like other authors (Cross, 
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Hillman et al. 1995, Ardawi, Nasrat et al. 1997), we found progressive increase in serum vitamin 
D with advancing gestational age and serum vitamin D levels were significantly higher in the 
third compared to the first trimester. Maternal and fetal serum vitamin D correlate and fetal 
serum vitamin D correlates with calcium (Hashemipour, Lalooha et al. 2013). Although, 
absorption of calcium from the gastro-intestinal tract increases throughout pregnancy, 80% of 
calcium in the fetal skeleton is deposited during the third trimester (Kovacs 2001). It is therefore 
postulated that the progressive increase of vitamin D with advancing gestational age possibly 
exerts anti-inflammatory effects to sustain pregnancy and increases production of antimicrobial 
peptides. Indeed, low serum vitamin D in pregnancy is associated with increased risk of preterm 
birth (Bodnar, Platt et al. 2015). 
 
Cervical ripening that occurs before the initiation of labour is an inflammatory process 
(Sennstrom, Ekman et al. 2000). It involves degradation of collagen fibres by the neutrophil-
derived matrix metalloproteinase 8 (Sennstrom, Brauner et al. 2003). Serum and cervical IL-8 
levels are elevated before cervical ripening and potentially predict preterm birth (Dowd, Laham 
et al. 2001, Tornblom, Klimaviciute et al. 2005, Shahshahan and Hashemi 2014).  
In paper III, we found significantly lower levels of IL-8 in the third compared to the first 
trimester, the low serum IL-8 levels in the third trimester may protect against preterm birth. We 
demonstrate for the first time that elevated vitamin D levels significantly decrease IL-8 in 
uroepithelial cells (paper III). In line with our results, vitamin D was reported to decrease IL-8 
secretion also in enterocytes (Hidaka, Wakabayashi et al. 2013).  
 
In addition to their barrier function, bladder epithelial cells mediate innate immune responses. 
They recognize bacterial LPS using TLR4 eventually leading to IL-8 production. CD14 is 
necessary in recognition of bacterial LPS in macrophages (Jiang, Georgel et al. 2005), however; 
its role at the bladder epithelium remains ambivalent. It is claimed that bladder epithelial cells 
don’t endogenously produce CD14 (Backhed, Meijer et al. 2002) and that type 1 fimbriae are 
essential in recognition of LPS among CD14 negative cells (Hedlund, Frendeus et al. 2001) 
while membrane-bound CD14 has been identified on different bladder epithelial cell lines 
(Schilling, Martin et al. 2003, Chromek, Stankowska et al. 2005). Despite disagreement on the 
isoform of CD14 present on bladder epithelial cells, it remains essential in the host response to 
bacterial LPS. CD14 lacks VDRE in its promoter region but vitamin D modulates its 
transcription through transcription factor Sp-1 (Moeenrezakhanlou, Nandan et al. 2008). In paper 
III, sCD14 didn’t increase with gestational age and serum vitamin D had no effect on CD14 
expression neither on mRNA nor protein levels. This could be protective against preterm birth 
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since CD14 facilitates LPS recognition leading to elevated levels of IL-8 – a mediator of cervical 
ripening. 
 
Close proximity of the urinary tract to the highly colonized gastro-intestinal tract in women 
notwithstanding, the prevalence of UTI remains low. Largely due to mechanical flow of urine, 
presence of type 1 fimbriae-neutralizing proteins likes Tamm Horsfall and antimicrobial 
peptides. Antimicrobial peptides including LL-37 and hBD-2 are constitutively produced at 
epithelial surfaces and upon stimulation in response to bacterial infection. In pregnancy, maternal 
and fetal LL-37 levels are positively correlated, however, serum levels LL-37 are higher among 
newborn babies delivered vaginally compared to those delivered by elective caesarean section 
(Mandic Havelka, Yektaei-Karin et al. 2010). LL-37 is also present in vernix caseosa potentially 
protecting the newborn against skin infections (Akinbi, Narendran et al. 2004).  Moreover, 
antimicrobial peptides act synergistically to guard against infectious pathogens (Chen, Niyonsaba 
et al. 2005). We found significantly higher serum LL-37 but not hBD-2 in the third compared to 
the first trimester among pregnant women. This is in keeping with correspondingly high levels of 
vitamin D in the third trimester, however, it may indicate that LL-37 is more important in 
protection against infections or modulating the immune response during parturition.  
 
The dearth in discovery of new antimicrobial agents in the face of a worsening global epidemic 
of antibiotic resistance calls for critical evaluation of medicinal herbs for their disease-modifying 
potential. Herbs have long been used for their medicinal value however; their mechanisms of 
action remain poorly understood. Recently, medicinal herbs have been found to exhibit 
antimicrobial, anti-inflammatory and biofilm inhibiting properties (Cheong, Lee et al. 2011, 
Thompson, Meah et al. 2013, Samoilova, Muzyka et al. 2014). Candidate medicinal herbs 
include those that have a long history of use in various communities, anecdotal reports of their 
effectiveness or continued use despite advent of modern therapeutic agents. In paper IV, we 
evaluated the effects of LPva on the pathogenesis of E. coli UTI using an in vitro model.  
 
As part of the pathogenesis of UTI, UPEC invade bladder epithelial cells through the interaction 
of bacterial type 1 fimbriae and host β-1 integrin (Martinez, Mulvey et al. 2000, Eto, Jones et al. 
2007). Intracellularly, they form intracellular bacterial communities (IBC) that are resistant to 
antimicrobial agents and are shielded from innate effector molecules. In cells deeper to the 
terminally differentiated bladder epithelium, non-replicating E. coli are enclosed in vesicles. 
These are referred to as quiescent intracellular reservoirs (QIR), however, with epithelial 
turnover, bacteria emerge to infect the bladder (Mysorekar and Hultgren 2006). QIR are therefore 
thought to be the hallmark of recurrent infections that are common in women (Robino, Scavone 
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et al. 2014). Conversely, as part of the host response to E. coli adhesion, apoptotic shedding of 
bladder epithelial cells occurs to reduce the bacterial load as cell-associated bacteria are washed 
out during micturition (Mulvey, Lopez-Boado et al. 1998). LPva had no antibacterial effect nor 
interacted with type 1 fimbriae. Nonetheless, it significantly reduced invasion of bladder 
epithelial cells and induced apoptosis in vitro. Similar effects were reported for Citrus reticulata 
(Vollmerhausen, Ramos et al. 2013). We report a potential mechanism of action that could be 
beneficial in UTI however, the application LPva in vivo requires further evaluation.  
 
UTI in pregnant women is of great public health importance since it can be complicated by 
involvement of the kidneys. This exposes the mother to not only poor pregnancy outcomes but 
life-threatening septicemia (Wing, Fassett et al. 2014). In pregnancy, UTI-like symptoms are 
common non-specific complaints. Therefore, clinical diagnosis of UTI is largely inaccurate and 
could lead to antibiotic misuse. Host factors like vitamin D and antimicrobial peptides potentially 
modulate the host response to infection. However, optimization of antimicrobial peptides in the 
management of infectious diseases is still challenging because they also modulate other cellular 
responses (Fjell, Hiss et al. 2012). Medicinal herbs have variously been found to modify 
infectious disease processes (Mwitari, Ayeka et al. 2013) but their toxicity profiles and 
interaction with prescription medicines remains to be elucidated (Alissa 2014).  
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    7 CONCLUSION 
 
The following conclusions are drawn from our results:- 
1. There is a high prevalence of antibiotic resistance among E. coli isolates from Uganda that 
manifests as ESBL and MDR. 
2. Limited access to or affordability of diagnostic services leads to massive antibiotic misuse 
in pregnant women. 
3. Vitamin D and LL-37 increased while IL-8 decreased with advancing gestational age  
4. LPva has beneficial effect against E. coli infection by preventing bacterial invasion and 
inducing apoptosis in uroepithelial cells in vitro.  
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8 FUTURE PERSPECTIVES 
The antimicrobial agents that are recommended for empiric management of UTI have limited 
effectiveness. Although the national clinical guidelines are regularly revised, there is need to have 
sentinel surveillance of antimicrobial resistance at regional hospitals to inform policy. This could be 
achieved by bacterial culture of urine specimens, identification of causative organisms and 
antimicrobial susceptibility testing. Additionally, isolates should be stored in both regional and 
national centers for evaluation of the genetic basis of their resistance phenotype.   
Maternal sepsis is among the leading causes of mortality and E. coli is the main causative organism 
especially among women with urinary tract infection. However, in low and middle-income 
countries, characterization of the risk factors of maternal sepsis, causative organisms and their 
susceptibility to antimicrobial agents has not attracted much attention. Moreover, little is known 
about the sources of these microbes and their relationship to the host and environment.  
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